Table 2: Clinical characteristics of patients (n = 42).
Clinical Characteristics | Number (n) | Frequency (%) | |
Type of AKI | Acquired in community | 38 | 90 |
Acquired in hospitalization | 4 | 10 | |
Total | 42 | 100 | |
Severity (KDIGO¶) | Stage 1 | 23 | 55 |
55 | 9 | 21 | |
Stage 3 | 10 | 24 | |
Total | 42 | 100 | |
Etiological factors N (65) | Dehydration | 16 | 38 |
Third space | 3 | 7 | |
Heart failure | 2 | 5 | |
Sepsis | 23 | 55 | |
Hypercalcemia | 2 | 5 | |
Functional drug | 1 | 2 | |
Malignant HBP* | 6 | 14 | |
Nephrotoxic drugs | 2 | 5 | |
Ischemic tubular necrosis | 3 | 7 | |
Toxic tubular necrosis | 2 | 5 | |
Bilateral pyelonephritis | 2 | 5 | |
Glomerulonephritis | 1 | 2 | |
Obstructive causes | 1 | 2 | |
Comorbidities | Diabetes | 6 | 14 |
HBP | 13 | 31 | |
Malignant neoplasia | 5 | 12 | |
Any | 8 | 19 | |
Cirrhosis | 4 | 10 | |
Other | 3 | 7 | |
HIV$ | 3 | 7 | |
Total | 42 | 100 | |
Dialysis rate | Dialysis | 4 | 9.5 |
No dialysis | 38 | 90.5 | |
Total | 42 | 100 |
*HBP: High blood pressure; ¶KDIGO: Kidney disease Improving global outcomes; $HIV: Human immunodeficiency virus.